Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Over-the-Counter

Akorn, Inc.: Eye Itch Relief (Ketotifen Fumarate) Recalled for Manufacturing Deviations

Agency Publication Date: October 1, 2020
Share:
Sign in to monitor this recall

Summary

Akorn, Inc. is recalling approximately 25,843 bottles of Eye Itch Relief (Ketotifen Fumarate) Ophthalmic Solution 0.035% because of deviations from Current Good Manufacturing Practice (CGMP) standards. This product is a sterile eye drop sold in 5 mL bottles under the CVS Pharmacy brand. Consumers should be aware that manufacturing deviations in sterile products can compromise the quality and safety of the medication.

Risk

The recall is due to manufacturing process deviations that do not meet sterile drug standards, which could potentially lead to product contamination or loss of efficacy. While no specific injuries have been reported, using a compromised ophthalmic solution can pose a risk of eye irritation or infection.

What You Should Do

  1. Check your medicine cabinet for CVS Pharmacy Eye Itch Relief (Ketotifen Fumarate Ophthalmic Solution 0.035%) in a 5 mL sterile bottle.
  2. Identify if your product is affected by looking for Lot 8A11A with an expiration date of 12/20 (December 2020) and NDC 59779-920-01 on the packaging.
  3. If you have the affected product, contact your healthcare provider or pharmacist for guidance regarding your eye care needs.
  4. Return any unused product to the CVS Pharmacy or place of purchase for a refund.
  5. Contact Akorn, Inc. for further instructions regarding this recall.
  6. For additional questions, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

๐Ÿ’ฐFull Refund

Drug product return and healthcare consultation.

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Eye Itch Relief, Ketotifen Fumarate Ophthalmic Solution 0.035%, Sterile (5 mL)
Model:
NDC 59779-920-01
Recall #: D-1628-2020
Lot Numbers:
8A11A (exp 12/20)
Date Ranges: Expiration Date 12/20

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 86361
Status: Resolved
Manufacturer: Akorn, Inc.
Sold By: CVS Pharmacy, Inc.
Manufactured In: United States
Units Affected: 25,843 bottles
Distributed To: California, Indiana, Virginia, New Jersey, New York, Rhode Island, Florida, Texas, Missouri, Pennsylvania, Michigan, Alabama, Tennessee, South Carolina

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.